Hoya Corp. (OTCMKTS:HOCPY - Get Free Report)'s share price reached a new 52-week high during trading on Wednesday . The company traded as high as $150.08 and last traded at $144.00, with a volume of 545 shares traded. The stock had previously closed at $147.28.
Analysts Set New Price Targets
A number of analysts recently weighed in on the stock. Erste Group Bank raised shares of Hoya from a "hold" rating to a "strong-buy" rating in a report on Friday, May 23rd. Nomura Securities raised Hoya to a "strong-buy" rating in a report on Monday, August 18th. Finally, The Goldman Sachs Group raised shares of Hoya from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, July 23rd. Three analysts have rated the stock with a Strong Buy rating, According to data from MarketBeat, Hoya has a consensus rating of "Strong Buy".
View Our Latest Stock Report on HOCPY
Hoya Stock Down 3.6%
The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.46 and a current ratio of 5.19. The stock's 50 day moving average price is $131.68 and its 200-day moving average price is $121.74. The company has a market cap of $47.89 billion, a PE ratio of 34.89, a PEG ratio of 3.09 and a beta of 0.94.
Hoya (OTCMKTS:HOCPY - Get Free Report) last posted its quarterly earnings results on Friday, August 1st. The technology company reported $1.05 earnings per share for the quarter, topping the consensus estimate of $1.04 by $0.01. Hoya had a net margin of 23.57% and a return on equity of 21.01%. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.47 billion. On average, analysts predict that Hoya Corp. will post 3.66 earnings per share for the current year.
About Hoya
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Recommended Stories
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.